How Fast Do Antimicrobial Lactoferricin Peptides Break Down in the Body?

Metabolic fate studies of lactoferricin-based peptides revealed truncation and amino acid analog incorporation improve proteolytic stability — guiding design of longer-lasting antimicrobial peptide drugs.

RPEP-017002010RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Metabolic fate studies of lactoferricin-based peptides revealed truncation and amino acid analog incorporation improve proteolytic stability — guiding design of longer-lasting antimicrobial peptide drugs.

Key Numbers

How They Did This

research study.

Why This Research Matters

Relevant for peptide research.

The Bigger Picture

Advances peptide research.

What This Study Doesn't Tell Us

See abstract.

Questions This Raises

  • ?Further research needed.

Trust & Context

Key Stat:
Key finding Metabolic fate studies of lactoferricin-based peptides revealed truncation and amino acid analog incorporation improve proteolytic stability — guiding
Evidence Grade:
emerging evidence.
Study Age:
Published in 2010.
Original Title:
Metabolic fate of lactoferricin-based antimicrobial peptides: effect of truncation and incorporation of amino acid analogs on the in vitro metabolic stability.
Published In:
The Journal of pharmacology and experimental therapeutics, 332(3), 1032-9 (2010)
Database ID:
RPEP-01700

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

What was studied?

How Fast Do Antimicrobial Lactoferricin Peptides Break Down in the Body?

What was found?

Metabolic fate studies of lactoferricin-based peptides revealed truncation and amino acid analog incorporation improve proteolytic stability — guiding design of longer-lasting antimicrobial peptide drugs.

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-01700·https://rethinkpeptides.com/research/RPEP-01700

APA

Svenson, Johan; Vergote, Valentijn; Karstad, Rasmus; Burvenich, Christian; Svendsen, John S; De Spiegeleer, Bart. (2010). Metabolic fate of lactoferricin-based antimicrobial peptides: effect of truncation and incorporation of amino acid analogs on the in vitro metabolic stability.. The Journal of pharmacology and experimental therapeutics, 332(3), 1032-9. https://doi.org/10.1124/jpet.109.162826

MLA

Svenson, Johan, et al. "Metabolic fate of lactoferricin-based antimicrobial peptides: effect of truncation and incorporation of amino acid analogs on the in vitro metabolic stability.." The Journal of pharmacology and experimental therapeutics, 2010. https://doi.org/10.1124/jpet.109.162826

RethinkPeptides

RethinkPeptides Research Database. "Metabolic fate of lactoferricin-based antimicrobial peptides..." RPEP-01700. Retrieved from https://rethinkpeptides.com/research/svenson-2010-metabolic-fate-of-lactoferricinbased

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.